Kim W, Doyle M aire E, Liu Z, Lao Q, Shin Y-K, Carlson OD, Kim HS, Thomas S, Napora JK, Lee EK, et al. Cannabinoids inhibit insulin receptor signaling in pancreatic $\beta$-cells. Diabetes. 2011;60(4):1198–1209.
Publications
2011
Hinault C, Kawamori D, Liew CW, Maier B, Hu J, Keller SR, Mirmira RG, Scrable H, Kulkarni RN. Delta 40 isoform of p53 controls b-cell proliferation and glucose homeostasis in mice. Diabetes. 2011;60(4):1210–1222.
Reiner T, Thurber G, Gaglia J, Vinegoni C, Liew CW, Upadhyay R, Kohler RH, Li L, Kulkarni RN, Benoist C, et al. Accurate measurement of pancreatic islet beta-cell mass using a second-generation fluorescent exendin-4 analog.. Proceedings of the National Academy of Sciences. 2011;108(31):12815–12820.
Lin W, Cao J, Liu J, Beshiri ML, Fujiwara Y, Francis J, Cherniack AD, Geisen C, Blair LP, Zou MR, et al. Loss of the RBP2 histone demethylase suppresses tumorigenesis in mice lacking Rb1 or Men1. Proceedings of the National Academy of Sciences. 2011;108(33):13379–13386.
Kawamori D, Akiyama M, Hu J, Hambro B, Kulkarni R. Growth factor signaling in the regulation of a-cell fate. Diabetes, Obesity and Metabolism. 2011;13:21–30.
Morioka T, Kulkarni RN. Pancreatic islet b-cell failure in obesity. Metabolic Basis of Obesity. 2011:199.
Spiegel AM, Carter-Su C, Taylor SI, Kulkarni RN. Mechanism of action of hormones that act at the cell surface. In: Williams textbook of endocrinology. Elsevier; 2011. pp. 62–82.
Folli F, Okada T, Perego C, Gunton J, Liew CW, Akiyama M, D\textquoterightAmico A, La Rosa S, Placidi C, Lupi R, et al. Altered insulin receptor signalling and $\beta$-cell cycle dynamics in type 2 diabetes mellitus. PLoS One. 2011;6(11):e28050.
Rowland KJ, Trivedi S, Lee D, Wan K, Kulkarni RN, Holzenberger M, Brubaker PL. Loss of glucagon-like peptide-2–induced proliferation following intestinal epithelial insulin-like growth factor-1–receptor deletion. Gastroenterology. 2011;141(6):2166–2175.
Lopez X, Cypess A, Manning R, O\textquoterightShea S, Kulkarni RN, Goldfine AB. Exogenous insulin enhances glucose-stimulated insulin response in healthy humans independent of changes in free fatty acids. The Journal of Clinical Endocrinology & Metabolism. 2011;96(12):3811–3821.